Companies, institutions, people, countries.

Seed nodes so the graph has neighbours. The person record is an explicit placeholder, not a referral.

Companies

Company
Biogen
Biogen partnered on lecanemab and previously marketed aducanumab.
Company
Eisai
Eisai is a medicines company that co-developed lecanemab.
Company
Eli Lilly
Lilly developed donanemab and is running further amyloid-antibody studies.

Institutions

Institution
Alzheimer's Association
A US nonprofit that publishes public pages on dementia types, symptoms, and medicines. It is not a clinic.
Institution
National Institute on Aging
The US National Institute on Aging publishes public pages on Alzheimer’s disease, MCI, and caregiving.
Institution
NICE
NICE publishes NG97 on dementia assessment, management, and support for people and carers in England.
Institution
UCL
University College London is a public research university. This node marks a UK academic neighbour, not a ranked best-centre list.

People

Person
Alois Alzheimer
Alois Alzheimer was a physician whose 1906 case description is why Alzheimer’s disease has that name. This is a historical biography, not a doctor to contact.

Countries on the access map

US, EU, UK, Japan, China, and Australia appear as region columns on the approvals page. This is not a ranking of health systems.